Literature DB >> 26250916

Umbilical Cord Blood-An Untapped Resource: Strategies to Decrease Early Red Blood Cell Transfusions and Improve Neonatal Outcomes.

Patrick D Carroll1.   

Abstract

Umbilical cord blood is a resource that is available to all neonates. Immediately after delivery of the fetus, cord blood can be used for the direct benefit of the premature infant. Delayed cord clamping and milking of the umbilical cord are 2 methods of transfusing additional fetal blood into the neonate after vaginal or cesarean delivery. Additionally, umbilical cord blood can be utilized for neonatal admission laboratory testing rather than direct neonatal phlebotomy. Together these strategies both increase initial neonatal total blood volume and limit immediate loss through phlebotomy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood; Delayed cord clamping; Intraventricular hemorrhage; Milking; Transfusion

Mesh:

Year:  2015        PMID: 26250916     DOI: 10.1016/j.clp.2015.04.017

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  3 in total

Review 1.  Iron Homeostasis Disruption and Oxidative Stress in Preterm Newborns.

Authors:  Genny Raffaeli; Francesca Manzoni; Valeria Cortesi; Giacomo Cavallaro; Fabio Mosca; Stefano Ghirardello
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

2.  Interventions to minimize blood loss in very preterm infants-A systematic review and meta-analysis.

Authors:  Emma Persad; Greta Sibrecht; Martin Ringsten; Simon Karlelid; Olga Romantsik; Tommy Ulinder; Israel Júnior Borges do Nascimento; Maria Björklund; Anneliese Arno; Matteo Bruschettini
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

3.  Primary hemostasis in fetal growth restricted neonates studied via PFA-100 in cord blood samples.

Authors:  Maria Kollia; Nicoletta Iacovidou; Zoi Iliodromiti; Abraham Pouliakis; Rozeta Sokou; Vasiliki Mougiou; Maria Boutsikou; Marianna Politou; Theodora Boutsikou; Serena Valsami
Journal:  Front Pediatr       Date:  2022-09-08       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.